[Possibilities of drug therapy of gynecologic malignancies].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000201:enzymology; D010472:Perchlorates; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D014364:Tryptophan; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000201:enzymology; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000201:enzymology
D000970:Antineoplastic Agents; D007527:Isoenzymes; D010472:Perchlorates; D014364:Tryptophan; D003520:Cyclophosphamide; D011033:Podophyllin; D007770:L-Lactate Dehydrogenase
Möglichkeiten der Chemotherapei gynäkologischer Malignome.